AKT1 and neoplasm: Additionally, this finding reveals important mechanistic insights into tumor therapeutic resistance development and provides a platform for testing other targeted therapies on PI3K/Akt/mTOR and c-Myc axis to achieve a sustainable therapeutic outcome.